Medical references
Every page on this site is built on published guidelines and sources. This page gathers those references in one place so any statement can be checked against its original source.
Sourcing standard
Professional society guidelines and systematic reviews come first: AAD, British Association of Dermatologists, NICE, Cochrane, WHO and FDA, alongside PubMed indexed studies. Pages are reviewed periodically, and any page last updated more than 12 months ago is marked as review due.
Articles (20)
Medical dermatology
Pigmentation
Hair and scalp
Pediatric dermatology
Telehealth
Chronic skin disease
Medical dermatology
- The frequency of warts among patients attending at department of dermatology and venereology, in Al-Sadar Hospital in Baghdad, IRAQ
- WHO EMRO - Prevalence of skin disorders among primary-school children in Baghdad governorate, Iraq
- Clinical guideline for the diagnosis and treatment of cutaneous warts (2022)
- American Academy of Dermatology - Warts: Diagnosis and treatment
Medical dermatology
Medical dermatology
Pediatric dermatology
- Layegh, P., Khosrojerdi, M., Azimian, A., Ghazvini, K., Torabi, S., & Tehami, M. The Role of Staphylococcus Aureus Types and Toxin-Producing Ability in Pediatric Atopic Dermatitis and its Association with Disease Severity. Journal of Pediatric Perspectives, Mashhad University of Medical Sciences.
- American Academy of Dermatology. Eczema types: atopic dermatitis overview and treatment.
- PubMed search: Staphylococcus aureus atopic dermatitis pediatric colonization.
- NICE. Atopic eczema in under 12s: diagnosis and management (CG57).
- Cochrane Library. Interventions to reduce Staphylococcus aureus in the management of atopic eczema.
- World Health Organization. Antimicrobial resistance fact sheet.
Hair and scalp
- American Academy of Dermatology. Hair loss types: alopecia areata diagnosis and treatment.
- British Association of Dermatologists. Alopecia areata patient information leaflet.
- US Food and Drug Administration. FDA approves first systemic treatment for alopecia areata (baricitinib), 2022.
- US Food and Drug Administration. FDA approves ritlecitinib for severe alopecia areata, 2023.
Pediatric dermatology
Hair and scalp
- American Academy of Dermatology. Alopecia areata: diagnosis and treatment.
- British Association of Dermatologists. Alopecia areata patient information leaflet.
- US Food and Drug Administration. FDA approves first systemic treatment for alopecia areata, 2022.
- US Food and Drug Administration. FDA approves ritlecitinib for severe alopecia areata, 2023.
Medical dermatology
- Thiboutot D, Anderson R, et al. Standard management options for rosacea: the 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2020;82(6):1501-1510.
- Gallo RL, Granstein RD, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78(1):148-155.
- van Zuuren EJ, Arents BWM, et al. Rosacea: new concepts in classification and treatment. Am J Clin Dermatol. 2021;22(4):457-465.
- American Academy of Dermatology. Rosacea: diagnosis and treatment.
- American Academy of Dermatology. Rosacea: overview, signs and symptoms.
- National Rosacea Society. Standard management options for rosacea.
Pediatric dermatology
- DermNet. Epidermal naevi: types, clinical features, lines of Blaschko, diagnosis and treatment.
- DermNet. Epidermal naevus syndromes.
- DermNet. Inflammatory linear verrucous epidermal naevus (ILVEN).
- Nicholson CL, Daveluy S. Epidermal nevus syndromes. StatPearls, NCBI Bookshelf.
- Orphanet. Epidermal nevus syndrome: neurological, ocular and skeletal associations and management.
Pediatric dermatology
- Krowchuk DP, et al. American Academy of Pediatrics clinical practice guideline for the management of infantile hemangiomas. Pediatrics. 2019;143(1):e20183475.
- International Society for the Study of Vascular Anomalies. ISSVA classification of vascular anomalies.
- DermNet. Port-wine stain (capillary malformation).
- DermNet. Infantile haemangioma.
- DermNet. Sturge-Weber syndrome and capillary malformations.
- DermNet. PHACE syndrome.
Pigmentation
- Sarkar R, Gokhale N, Godse K, et al. Medical management of melasma: a review with consensus recommendations by Indian pigmentary expert group. Indian J Dermatol. 2017;62(6):558-577.
- Mahmoud BH, Ruvolo E, Hexsel CL, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol. 2010;130(8):2092-2097.
- Alwan A, Hameed A, Hamad N. Analyzing of UV index with the time variation for Baghdad. Iraqi J Ind Res. 2021;8(1):50-54.
- World Health Organization, WMO, UNEP, ICNIRP. Global solar UV index: a practical guide. Geneva: WHO; 2002.
- Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20-31.
- Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462-1470.
- Hughes EK, Brady MF, Rawla P. Acanthosis nigricans. In: StatPearls. StatPearls Publishing; updated 11 August 2023.
- Rajaratnam R, Halpern J, Salim A, Emmett C. Interventions for melasma. Cochrane Database Syst Rev. 2010;(7):CD003583.
- Sarkar R, Desai SR, Sinha S, Dogra S, et al.; Pigmentary Disorders Society. Delphi consensus on melasma management by international experts and pigmentary disorders society. J Eur Acad Dermatol Venereol. 2026;40(4):680-692 (epub 2025).
- Rendon M, Berneburg M, Arellano I, Picardo M. Treatment of melasma. J Am Acad Dermatol. 2006;54(5 Suppl 2):S272-S281.
- Del Rosario E, Florez-Pollack S, Zapata L Jr, et al. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma. J Am Acad Dermatol. 2018;78(2):363-369.
- Zhang L, Tan WQ, Fang QQ, et al. Tranexamic acid for adults with melasma: a systematic review and meta-analysis. Biomed Res Int. 2018;2018:1683414.
- Lysteda (tranexamic acid) tablets, US Prescribing Information, NDA 022430: contraindications.
- Wu BQ, Wang YJ, Chang CC, Juang TY, Huang YH, Hsu YC. Clinical efficacy of cysteamine application for melasma: a meta-analysis. J Clin Med. 2024;13(23):7483.
- Castanedo-Cazares JP, Hernandez-Blanco D, Carlos-Ortega B, Fuentes-Ahumada C, Torres-Alvarez B. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Photodermatol Photoimmunol Photomed. 2014;30(1):35-42.
- Boukari F, Jourdan E, Fontas E, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol. 2015;72(1):189-190.e1.
- Sarkar R, Arsiwala S, Dubey N, et al. Chemical peels in melasma: a review with consensus recommendations by Indian pigmentary expert group. Indian J Dermatol. 2017;62(6):578-584.
- Bailey AJM, Li HOY, Tan MG, Cheng W, Dover JS. Microneedling as an adjuvant to topical therapies for melasma: a systematic review and meta-analysis. J Am Acad Dermatol. 2022;86(4):797-810.
- Trivedi MK, Yang FC, Cho BK. A review of laser and light therapy in melasma. Int J Womens Dermatol. 2017;3(1):11-20.
- Khalili M, Amiri R, Iranmanesh B, Zartab H, Aflatoonian M. Safety and efficacy of mesotherapy in the treatment of melasma: a review article. J Cosmet Dermatol. 2022;21(1):118-129.
Cosmetic dermatology
- Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462-1470.
- Guyuron B, Rowe DJ, Weinfeld AB, Eshraghi Y, Fathi A, Iamphongsai S. Factors contributing to the facial aging of identical twins. Plast Reconstr Surg. 2009;123(4):1321-1331.
- Cho S, Shin MH, Kim YK, et al. Effects of infrared radiation and heat on human skin aging in vivo. J Investig Dermatol Symp Proc. 2009;14(1):15-19.
- Alwan A, Hameed A, Hamad N. Analyzing of UV index with the time variation for Baghdad. Iraqi J Ind Res. 2021;8(1):50-54.
- World Health Organization, WMO, UNEP, ICNIRP. Global solar UV index: a practical guide. Geneva: WHO; 2002.
- Allergan/AbbVie. BOTOX Cosmetic (onabotulinumtoxinA) Prescribing Information, including the boxed warning on distant spread of toxin effect.
- NHS. Botox injections (cosmetic procedures).
- Beer KR, Boyd C, Patel RK, Bowen B, James SP, Brin MF. Rapid onset of response and patient-reported outcomes after onabotulinumtoxinA treatment of moderate-to-severe glabellar lines. J Drugs Dermatol. 2011;10(1):39-44.
- Glogau R, Kane M, Beddingfield F, Somogyi C. OnabotulinumtoxinA: a meta-analysis of duration of effect in the treatment of glabellar lines. Dermatol Surg. 2012;38(11):1794-1803.
- Carruthers A, Carruthers J, Fagien S, Lei X, Kolodziejczyk J, Brin MF. Repeated onabotulinumtoxinA treatment of glabellar lines at rest over three treatment cycles. Dermatol Surg. 2016;42(9):1094-1101.
- Binder WJ. Long-term effects of botulinum toxin type A (Botox) on facial lines: a comparison in identical twins. Arch Facial Plast Surg. 2006;8(6):426-431.
- Hughes MCB, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med. 2013;158(11):781-790.
- US FDA. Counterfeit version of Botox found in multiple states. Drug Safety and Availability alert, 17 April 2024.
- US FDA approval history of BOTOX Cosmetic (onabotulinumtoxinA): frown lines 2002, crow's feet 2013, forehead lines 2017, platysma bands 2024. Drugs.com approval history and Healio report, 21 October 2024.
Procedure guides (41)
Injectable treatments
- Allergan/AbbVie. BOTOX Cosmetic (onabotulinumtoxinA) Prescribing Information, including the boxed warning on distant spread of toxin effect.
- US FDA approval history of BOTOX Cosmetic (onabotulinumtoxinA): frown lines 2002, crow's feet 2013, forehead lines 2017, platysma bands 2024. Drugs.com approval history and Healio report, 21 October 2024.
- Allergan/AbbVie. BOTOX (onabotulinumtoxinA) Prescribing Information: chronic migraine and severe primary axillary hyperhidrosis indications.
- Heckmann M, Ceballos-Baumann AO, Plewig G; Hyperhidrosis Study Group. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med. 2001;344(7):488-493.
- Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Iyer S. Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg. 2002;28(9):822-827.
- Weinberg T, Solish N, Murray C. Botulinum neurotoxin treatment of palmar and plantar hyperhidrosis. Dermatol Clin. 2014;32(4):505-515.
- Dodick DW, Turkel CC, DeGryse RE, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50(6):921-936.
- Bendtsen L, Sacco S, Ashina M, et al. Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation. J Headache Pain. 2018;19(1):91.
- Bello RJ, Cooney CM, Melamed E, et al. The therapeutic efficacy of botulinum toxin in treating scleroderma-associated Raynaud's phenomenon: a randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol. 2017;69(8):1661-1669.
- Senet P, Maillard H, Diot E, et al. Efficacy and safety of botulinum toxin in adults with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheumatol. 2023;75(3):459-467.
- Geary E, Wormald JCR, Cronin KJ, et al. Toxin for Treating Raynaud Conditions in Hands (The TORCH Study): a systematic review and meta-analysis. Plast Reconstr Surg Glob Open. 2024;12(6):e5885.
- Park JY, Park S, Lee JS, Lee DH. Efficacy and safety of incobotulinumtoxin-A for trapezius muscle reduction: quantitative evaluation with imaging studies. Plast Reconstr Surg Glob Open. 2025;13(5):e6782.
- Beer KR, Boyd C, Patel RK, Bowen B, James SP, Brin MF. Rapid onset of response and patient-reported outcomes after onabotulinumtoxinA treatment of moderate-to-severe glabellar lines. J Drugs Dermatol. 2011;10(1):39-44.
- Glogau R, Kane M, Beddingfield F, Somogyi C. OnabotulinumtoxinA: a meta-analysis of duration of effect in the treatment of glabellar lines. Dermatol Surg. 2012;38(11):1794-1803.
- NHS. Botox injections (cosmetic procedures).
- Carruthers A, Carruthers J, Fagien S, Lei X, Kolodziejczyk J, Brin MF. Repeated onabotulinumtoxinA treatment of glabellar lines at rest over three treatment cycles. Dermatol Surg. 2016;42(9):1094-1101.
- Binder WJ. Long-term effects of botulinum toxin type A (Botox) on facial lines: a comparison in identical twins. Arch Facial Plast Surg. 2006;8(6):426-431.
- Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462-1470.
- US FDA. Counterfeit version of Botox found in multiple states. Drug Safety and Availability alert, 17 April 2024.
- FDA new established names for botulinum toxin products (onabotulinumtoxinA, abobotulinumtoxinA, rimabotulinumtoxinB) and units that are not interchangeable, 2009. Dermatology Times.
- Fedorowicz Z, van Zuuren EJ, Schoones J. Botulinum toxin for masseter hypertrophy. Cochrane Database Syst Rev. 2013;(9):CD007510.
- Ghatge AS, Ghatge SB, Mehta V. A review on bigonial width reduction by botulinum toxin injections in masseter. Bioinformation. 2023;19(3):272-277.
- Ferrillo M, Sommadossi E, Raciti L, et al. The role of botulinum toxin for masseter muscle hypertrophy: a comprehensive review. Toxins (Basel). 2025;17(2):91.
- Rojo-Sanchis C, Montiel-Company JM, Tarazona-Alvarez B, et al. Non-surgical management of the gingival smile with botulinum toxin A: a systematic review and meta-analysis. J Clin Med. 2023;12(4):1433.
- Rahman E, Rao P, Philipp-Dormston W, et al. Intradermal botulinum toxin A on skin quality and facial rejuvenation: a systematic review and meta-analysis. Plast Reconstr Surg Glob Open. 2024;12(8):e6084.
- Bi M, Sun P, Li D, Dong Z, Chen Z. Intralesional injection of botulinum toxin type A compared with intralesional injection of corticosteroid for the treatment of hypertrophic scar and keloid: a systematic review and meta-analysis. Med Sci Monit. 2019;25:2950-2958.
- Yang HA, Jheng WL, Yu J, Huang JY, Cheng KY, Lee JJ. Comparative efficacy of drug interventions for keloids: a network meta-analysis. Ann Plast Surg. 2024;92(1S Suppl 1):S52-S59.
Injectable treatments
- Fallacara A, Manfredini S, Durini E, et al. Hyaluronic acid fillers in soft tissue regeneration. Facial Plastic Surgery.
- Signorini M, Liew S, Sundaram H, et al. Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers. Plastic and Reconstructive Surgery.
- British Association of Dermatologists patient information on cosmetic injectable treatments.
Injectable treatments
- Krastev TK, Beugels J, Hommes J, et al. Efficacy and safety of autologous fat transfer in facial reconstructive surgery: a systematic review and meta-analysis. JAMA Facial Plast Surg. 2018;20(5):351-360.
- Gornitsky J, Viezel-Mathieu A, Alnaif N, Azzi AJ, Gilardino MS. A systematic review of the effectiveness and complications of fat grafting in the facial region. JPRAS Open. 2019;19:87-97.
- Vermeersch N, De Fre M, Verhoeven V, Hunter JE, Tondu T, Thiessen FEF. Autologous fat transfer for hand rejuvenation: a systematic review on technique and outcome. JPRAS Open. 2022;32:182-194.
- El Sewify O, Zhu XM, Tremblay C, Delisle E, Shahrokhi S. The utility of fat grafting to manage burn scars: a systematic review. J Burn Care Res. 2025;46(6):1269-1275.
- Riyat H, Touil LL, Briggs M, Shokrollahi K. Autologous fat grafting for scars, healing and pain: a review. Scars Burn Heal. 2017;3:2059513117728200.
- Tonnard P, Verpaele A, Peeters G, Hamdi M, Cornelissen M, Declercq H. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2013;132(4):1017-1026.
- Al-sabri G, Alavi S, Alkaabi S, Maningky M, Forouzanfar T, Helder M. The effectiveness of nanofat in the management of skin scars: a systematic review. Aesthet Surg J Open Forum. 2025;7:ojaf080.
- Schiraldi L, Sapino G, Meuli J, et al. Facial fat grafting (FFG): worth the risk? A systematic review of complications and critical appraisal. J Clin Med. 2022;11(16):4708.
- Lazzeri D, Agostini T, Figus M, Nardi M, Pantaloni M, Lazzeri S. Blindness following cosmetic injections of the face. Plast Reconstr Surg. 2012;129(4):995-1012.
Injectable treatments
Injectable treatments
Injectable treatments
- Haute Autorite de Sante (HAS, France). Assessment of the risks associated with aesthetic mesotherapy practices. June 2014.
- Nazem S, Mohammadnejad A. Depth of treatment in the facial rejuvenation: the neglected point in facial mesotherapy. J Plast Reconstr Surg. 2023;2(1):34-36.
- Baspeyras M, Rouvrais C, Liegard L, et al. Clinical and biometrological efficacy of a hyaluronic acid-based mesotherapy product: a randomised controlled study. Arch Dermatol Res. 2013;305(8):673-682.
- Mammucari M, Russo D, Maggiori E, et al. Consensus statement on mesotherapy for clinical and regulatory practice. Rheumatol Int. 2026;46(2):39.
- Khalili M, Amiri R, Iranmanesh B, Zartab H, Aflatoonian M. Safety and efficacy of mesotherapy in the treatment of melasma: a review article. J Cosmet Dermatol. 2022;21(1):118-129.
Injectable treatments
- Alves R, Grimalt R. A review of platelet rich plasma: history, biology, mechanism of action and classification. Skin Appendage Disorders.
- Gupta AK, Carviel JL. Meta analysis of efficacy of platelet rich plasma therapy for androgenetic alopecia. Journal of Dermatological Treatment.
- Kang C, Lu D. Combined effect of microneedling and platelet-rich plasma for the treatment of acne scars: a meta-analysis. Front Med (Lausanne). 2022;8:788754.
- Cruciani M, Masiello F, Pati I, Pupella S, De Angelis V. Platelet rich plasma for facial rejuvenation: an overview of systematic reviews. Blood Transfus. 2024;22(5):429-440.
Injectable treatments
- Richards RN. Update on intralesional steroid: focus on dermatoses. Journal of Cutaneous Medicine and Surgery.
- Gold MH, Berman B, Clementoni MT, et al. Updated international clinical recommendations on scar management. Dermatologic Surgery.
- Meah N, Wall D, York K, et al. The Alopecia Areata Consensus of Experts (ACE) study. Journal of the American Academy of Dermatology.
Injectable treatments
- Nawrocki S, Cha J. The etiology, diagnosis and management of hyperhidrosis: a comprehensive review. Journal of the American Academy of Dermatology.
- Allergan/AbbVie. BOTOX (onabotulinumtoxinA) Prescribing Information: chronic migraine and severe primary axillary hyperhidrosis indications.
- Heckmann M, Ceballos-Baumann AO, Plewig G; Hyperhidrosis Study Group. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med. 2001;344(7):488-493.
- Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Iyer S. Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg. 2002;28(9):822-827.
- Weinberg T, Solish N, Murray C. Botulinum neurotoxin treatment of palmar and plantar hyperhidrosis. Dermatol Clin. 2014;32(4):505-515.
Skin resurfacing
- Sitohang IBS, Sirait SAP, Suryanegara J. Microneedling in the treatment of atrophic scars: a systematic review of randomised controlled trials. Int Wound J. 2021;18(5):577-585.
- Kang C, Lu D. Combined effect of microneedling and platelet-rich plasma for the treatment of acne scars: a meta-analysis. Front Med (Lausanne). 2022;8:788754.
- Bailey AJM, Li HOY, Tan MG, Cheng W, Dover JS. Microneedling as an adjuvant to topical therapies for melasma: a systematic review and meta-analysis. J Am Acad Dermatol. 2022;86(4):797-810.
- Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20-31.
Skin resurfacing
Skin resurfacing
- Khunger N; IADVL Task Force. Standard guidelines of care for chemical peels. Indian J Dermatol Venereol Leprol. 2008;74(Suppl):S5-S12.
- Desai M, Gill J, Luke J. Cosmetic procedures in patients with skin of color: clinical pearls and pitfalls. J Clin Aesthet Dermatol. 2023;16(3):37-40.
- Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20-31.
- Sarkar R, Arsiwala S, Dubey N, et al. Chemical peels in melasma: a review with consensus recommendations by Indian pigmentary expert group. Indian J Dermatol. 2017;62(6):578-584.
- Chen X, Wang S, Yang M, Li L. Chemical peels for acne vulgaris: a systematic review of randomised controlled trials. BMJ Open. 2018;8(4):e019607.
- Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30.
Skin resurfacing
Skin resurfacing
- Manstein D, Herron GS, Sink RK, et al. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers in Surgery and Medicine.
- Alexis AF. Lasers and light based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. British Journal of Dermatology.
- American Academy of Dermatology clinical guidelines.
Skin resurfacing
Skin resurfacing
Skin resurfacing
Skin resurfacing
Skin resurfacing
- Mammucari M, Russo D, Maggiori E, et al. Consensus statement on mesotherapy for clinical and regulatory practice. Rheumatol Int. 2026;46(2):39.
- Haute Autorite de Sante (HAS, France). Assessment of the risks associated with aesthetic mesotherapy practices. June 2014.
- Sitohang IBS, Sirait SAP, Suryanegara J. Microneedling in the treatment of atrophic scars: a systematic review of randomised controlled trials. Int Wound J. 2021;18(5):577-585.
- Kang C, Lu D. Combined effect of microneedling and platelet-rich plasma for the treatment of acne scars: a meta-analysis. Front Med (Lausanne). 2022;8:788754.
- Bailey AJM, Li HOY, Tan MG, Cheng W, Dover JS. Microneedling as an adjuvant to topical therapies for melasma: a systematic review and meta-analysis. J Am Acad Dermatol. 2022;86(4):797-810.
- Baspeyras M, Rouvrais C, Liegard L, et al. Clinical and biometrological efficacy of a hyaluronic acid-based mesotherapy product: a randomised controlled study. Arch Dermatol Res. 2013;305(8):673-682.
- Nazem S, Mohammadnejad A. Depth of treatment in the facial rejuvenation: the neglected point in facial mesotherapy. J Plast Reconstr Surg. 2023;2(1):34-36.
Energy and light devices
Energy and light devices
Energy and light devices
Energy and light devices
Energy and light devices
Energy and light devices
- Elmets CA, Lim HW, et al. Joint American Academy of Dermatology and National Psoriasis Foundation guidelines of care for the management of psoriasis with phototherapy.
- Taieb A, Picardo M, et al. Guidelines for the management of vitiligo: the European Dermatology Forum consensus. British Journal of Dermatology.
- American Academy of Dermatology clinical guidelines.
Energy and light devices
Energy and light devices
Dermatologic surgery
Dermatologic surgery
Dermatologic surgery
- Jellinek NJ. Nail matrix biopsy of longitudinal melanonychia: diagnostic algorithm including the matrix shave biopsy. Journal of the American Academy of Dermatology.
- Eekhof JAH, Van Wijk B, Knuistingh Neven A, van der Wouden JC. Interventions for ingrowing toenails. Cochrane Database of Systematic Reviews.
- Cochrane Library.
Dermatologic surgery
Diagnostic procedures
- Nischal U, Nischal KC, Khopkar U. Techniques of skin biopsy and practical considerations. Journal of Cutaneous and Aesthetic Surgery.
- Swetter SM, Tsao H, et al. Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology.
- American Academy of Dermatology clinical guidelines.
Diagnostic procedures
- Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta analysis. British Journal of Dermatology.
- Salerni G, Carrera C, et al. Benefits of total body photography and digital dermatoscopy in the early diagnosis of melanoma. Journal of the American Academy of Dermatology.
Diagnostic procedures
- Johansen JD, Aalto Korte K, Agner T, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing. Contact Dermatitis.
- Uter W, Werfel T, White IR, Johansen JD. Contact allergy: a review of current problems from a clinical perspective. International Journal of Environmental Research and Public Health.
- British Association of Dermatologists patient information leaflets.
Energy and light devices
- Mechanisms of non-invasive ultrasound body contouring: a review of cavitation physics and tissue selectivity.
- Clinical trials of low frequency ultrasound for circumference reduction in the abdomen and flanks.
- Serum lipid and liver enzyme safety data following non-invasive ultrasound fat reduction.
- FDA guidance on non-invasive body contouring devices.
Skin resurfacing
- Sitohang IBS, Sirait SAP, Suryanegara J. Microneedling in the treatment of atrophic scars: a systematic review of randomised controlled trials. Int Wound J. 2021;18(5):577-585.
- Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20-31.
- Kang C, Lu D. Combined effect of microneedling and platelet-rich plasma for the treatment of acne scars: a meta-analysis. Front Med (Lausanne). 2022;8:788754.
- Bailey AJM, Li HOY, Tan MG, Cheng W, Dover JS. Microneedling as an adjuvant to topical therapies for melasma: a systematic review and meta-analysis. J Am Acad Dermatol. 2022;86(4):797-810.
- Khalili M, Amiri R, Iranmanesh B, Zartab H, Aflatoonian M. Safety and efficacy of mesotherapy in the treatment of melasma: a review article. J Cosmet Dermatol. 2022;21(1):118-129.
- Baspeyras M, Rouvrais C, Liegard L, et al. Clinical and biometrological efficacy of a hyaluronic acid-based mesotherapy product: a randomised controlled study. Arch Dermatol Res. 2013;305(8):673-682.
- Haute Autorite de Sante (HAS, France). Assessment of the risks associated with aesthetic mesotherapy practices. June 2014.
- Mammucari M, Russo D, Maggiori E, et al. Consensus statement on mesotherapy for clinical and regulatory practice. Rheumatol Int. 2026;46(2):39.
Dermatologic surgery
Dermatologic surgery
- Functional visual field impairment from dermatochalasis and outcomes after upper blepharoplasty.
- Differentiating dermatochalasis, brow ptosis and levator dysfunction in the ageing upper eyelid.
- Complications of upper eyelid surgery including retrobulbar haemorrhage: incidence and management.
- British Association of Dermatologists patient information on eyelid and periocular procedures.
Diagnostic procedures
Dermatologic surgery
Dermatologic surgery
- Management of cutaneous abscess: incision and drainage, packing and adjunctive antibiotics.
- Adjunctive antibiotics after drainage of uncomplicated skin abscesses in the era of community MRSA.
- Hidradenitis suppurativa: diagnosis and management guidance.
- NICE guidance on skin and soft tissue infection management.
